Theseus Pharmaceuticals Inc. (THRX) NASDAQ
$4.06 - (-)
Market Cap: -
As of 02/13/24 12:00 AM EST. Market closed.
Theseus Pharmaceuticals Inc. (THRX)
NASDAQ
$4.06
- (-)
Market Cap: -
As of 02/13/24 12:00 AM EST. Market closed.
theseus pharmaceuticals is passionately committed to outsmarting cancer resistance. cancer is constantly mutating, allowing it to evade initially effective oncology treatments. theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance. led by a team of pioneers in the discovery and ... read more
theseus pharmaceuticals is passionately committed to outsmarting cancer resistance. cancer is constantly mutating, allowing it to evade initially effective oncology treatments. theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance. led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (tkis), we are developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Shakespeare William | See Remarks | Nov 06, 2023 | Option Exercise | $0.32 | 251,084 | 80,347 | 639,408 | Nov 07, 2023, 04:03 PM |
GORDON CARL L | Director | Jul 17, 2023 | Buy | $3.05 | 479,932 | 1,463,793 | 17,063,000 | Jul 19, 2023, 04:17 PM |
ORBIMED ADVISORS LLC | Director | Jul 17, 2023 | Buy | $3.05 | 479,932 | 1,463,793 | 17,063,000 | Jul 19, 2023, 04:15 PM |
Foresite Capital Management V, LLC | 10% Owner | Jul 17, 2023 | Buy | $2.97 | 700,000 | 2,079,000 | 4,108,796 | Jul 19, 2023, 02:54 PM |
Foresite Capital Management V, LLC | 10% Owner | Dec 29, 2022 | Buy | $5.00 | 500,000 | 2,500,000 | 3,585,346 | Jan 03, 2023, 04:24 PM |
HAYDEN DONALD J JR | Director | Dec 29, 2022 | Buy | $5.00 | 100 | 500 | 100 | Jan 03, 2023, 07:05 AM |
HAYDEN DONALD J JR | Director | Dec 30, 2022 | Buy | $5.00 | 9,900 | 49,489 | 10,000 | Jan 03, 2023, 07:05 AM |
Dahms Bradford D. | Chief Financial Officer | Nov 30, 2022 | Buy | $6.66 | 1,502 | 9,999 | 6,142 | Dec 01, 2022, 04:35 PM |
CLACKSON TIMOTHY P | President and CEO | Nov 11, 2022 | Buy | $6.80 | 2,500 | 16,995 | 351,030 | Nov 14, 2022, 04:12 PM |
GORDON CARL L | Director | Nov 07, 2022 | Buy | $5.21 | 192,000 | 1,000,320 | 16,734,518 | Nov 09, 2022, 04:29 PM |
ORBIMED ADVISORS LLC | Director | Nov 07, 2022 | Buy | $5.21 | 192,000 | 1,000,320 | 16,734,518 | Nov 09, 2022, 04:25 PM |
GORDON CARL L | Director | Jan 20, 2022 | Buy | $9.95 | 35,000 | 348,250 | 16,430,756 | Jan 21, 2022, 07:22 PM |
GORDON CARL L | Director | Jan 19, 2022 | Buy | $9.97 | 11,521 | 114,864 | 16,395,756 | Jan 21, 2022, 07:22 PM |
GORDON CARL L | Director | Jan 21, 2022 | Buy | $9.97 | 111,896 | 1,115,603 | 16,542,652 | Jan 21, 2022, 07:22 PM |
ORBIMED ADVISORS LLC | Director | Jan 21, 2022 | Buy | $9.97 | 111,896 | 1,115,603 | 16,542,652 | Jan 21, 2022, 07:18 PM |
ORBIMED ADVISORS LLC | Director | Jan 20, 2022 | Buy | $9.95 | 35,000 | 348,250 | 16,430,756 | Jan 21, 2022, 07:18 PM |
ORBIMED ADVISORS LLC | Director | Jan 19, 2022 | Buy | $9.97 | 11,521 | 114,864 | 16,395,756 | Jan 21, 2022, 07:18 PM |
GORDON CARL L | Director | Jan 11, 2022 | Buy | $10.51 | 8,500 | 89,319 | 16,348,018 | Jan 13, 2022, 07:27 PM |
GORDON CARL L | Director | Jan 13, 2022 | Buy | $9.43 | 17,320 | 163,328 | 16,384,235 | Jan 13, 2022, 07:27 PM |
GORDON CARL L | Director | Jan 12, 2022 | Buy | $10.06 | 18,897 | 190,104 | 16,366,915 | Jan 13, 2022, 07:27 PM |
ORBIMED ADVISORS LLC | Director | Jan 13, 2022 | Buy | $9.43 | 17,320 | 163,328 | 16,384,235 | Jan 13, 2022, 07:18 PM |
ORBIMED ADVISORS LLC | Director | Jan 12, 2022 | Buy | $10.06 | 18,897 | 190,104 | 16,366,915 | Jan 13, 2022, 07:18 PM |
ORBIMED ADVISORS LLC | Director | Jan 11, 2022 | Buy | $10.51 | 8,500 | 89,319 | 16,348,018 | Jan 13, 2022, 07:18 PM |
CLACKSON TIMOTHY P | President and CEO | Dec 21, 2021 | Buy | $9.76 | 2,600 | 25,381 | 348,530 | Dec 22, 2021, 06:26 PM |
Dahms Bradford D. | Chief Financial Officer | Dec 21, 2021 | Buy | $10.15 | 1,970 | 20,000 | 1,970 | Dec 22, 2021, 06:21 PM |
GORDON CARL L | Director | Oct 12, 2021 | Buy | $16.00 | 62,500 | 1,000,000 | 499,150 | Oct 14, 2021, 05:00 PM |
GORDON CARL L | Director | Oct 12, 2021 | Buy | $16.00 | 562,500 | 9,000,000 | 16,339,518 | Oct 14, 2021, 05:00 PM |
Shakespeare William | See Remarks | Oct 12, 2021 | Buy | $16.00 | 625 | 10,000 | 388,949 | Oct 14, 2021, 05:00 PM |
Rock Springs Capital Management LP | 10% Owner | Oct 12, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 599,320 | Oct 14, 2021, 05:00 PM |
ORBIMED ADVISORS LLC | Director | Oct 12, 2021 | Buy | $16.00 | 62,500 | 1,000,000 | 499,150 | Oct 14, 2021, 05:00 PM |
ORBIMED ADVISORS LLC | Director | Oct 12, 2021 | Buy | $16.00 | 562,500 | 9,000,000 | 16,339,518 | Oct 14, 2021, 05:00 PM |
Omega Fund VI, L.P. | Former 10% owner | Oct 12, 2021 | Buy | $16.00 | 187,500 | 3,000,000 | 711,479 | Oct 14, 2021, 04:40 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ORBIMED ADVISORS LLC | 17,713,600 | 1.43% | No change | Other |
BLACKROCK INC. | 1,425,234 | 0.00015% | 6.32% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 407,822 | 0.00017% | 0.55% | Other |
RENAISSANCE TECHNOLOGIES LLC | 271,600 | 0.0017% | 115.22% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 232,693 | 0.00814% | Exited | Growth |
UBS OCONNOR LLC | 12,517 | 0.00365% | -93.1% | Value |
Period of Report: 09/30/2023
10-K/10-Q Filings: View